Cita APA

Calvet, J., Gratacos, J., Amengual, M., Llop, M., Navarro, M., Moreno, A., . . . Cervantes, M. (2020). CD4 and CD8 Lymphocyte Counts as Surrogate Early Markers for Progression in SARS-CoV-2 Pneumonia: A Prospective Study.

Citación estilo Chicago

Calvet, J., et al. CD4 and CD8 Lymphocyte Counts As Surrogate Early Markers for Progression in SARS-CoV-2 Pneumonia: A Prospective Study. 2020.

Cita MLA

Calvet, J., et al. CD4 and CD8 Lymphocyte Counts As Surrogate Early Markers for Progression in SARS-CoV-2 Pneumonia: A Prospective Study. 2020.